{"id":1263,"date":"2021-01-18T17:04:00","date_gmt":"2021-01-18T17:04:00","guid":{"rendered":"https:\/\/pprd.theramex.com\/ro\/?p=1263"},"modified":"2021-06-22T17:12:49","modified_gmt":"2021-06-22T14:12:49","slug":"theramex-lanseaza-livogiva","status":"publish","type":"post","link":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/","title":{"rendered":"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe"},"content":{"rendered":"\n

Londra, 18 ianuarie 2021: <\/strong>Theramex a lansat ast\u0103zi Livogiva\u00ae pentru pacien\u021bii din Europa, pentru prima dat\u0103. Tratamentul a fost lansat ini\u021bial \u00een Germania, urm\u00e2nd s\u0103 fie disponibil \u00een cur\u00e2nd \u0219i \u00een alte \u021b\u0103ri din UE, inclusiv Fran\u021ba, Italia \u0219i Spania. Livogiva este o nou\u0103 form\u0103 de prezentare a teriparatidei, singurul tratament pentru osteoporoz\u0103 cu mecanism anabolizant osos, dezvoltat sub forma unui stilou injector (pen) preumplut pentru a-l face mai u\u0219or de utilizat la pacien\u021bii cu risc crescut de fractur\u0103.<\/p>\n\n\n\n

Osteoporoza este \u00een continuare sub-diagnosticat\u0103 \u0219i sub-tratat\u0103 \u00een Europa, av\u00e2nd ca rezultat un num\u0103r ridicat de fracturi. \u00cen r\u00e2ndul popula\u021biei cu v\u00e2rsta peste 50 de ani, una din trei femei \u0219i unul din cinci b\u0103rba\u021bi va suferi o fractur\u0103 de fragilitate.1<\/sup> Fracturile la nivelul \u0219oldului, coloanei vertebrale \u0219i \u00eencheieturii m\u00e2inii sunt cel mai frecvent \u00eent\u00e2lnite fracturi, av\u00e2nd un impact debilitant asupra activit\u0103\u021bilor zilnice \u0219i calit\u0103\u021bii vie\u021bii.1<\/sup><\/p>\n\n\n\n

\u201e\u00cembun\u0103t\u0103\u021birea s\u0103n\u0103t\u0103\u021bii femeii este obiectivul nostru cheie la Theramex, iar angajamentul nostru de a sprijini persoanele cu osteoporoz\u0103 este o parte important\u0103 \u00een cadrul acestuia. Lansarea Livogiva, un produs biosimilar, \u00een noul stilou injector (pen) preumplut, va extinde gama din care pacien\u021bii pot alege \u0219i va permite mai multor femei s\u0103 aib\u0103 acces la aceste medicamente importante. Aceast\u0103 nou\u0103 completare aduce un plus portofoliului nostru extins de medicamente pentru toate stadiile osteoporozei, \u00eencep\u00e2nd de la preven\u021bie prin administrarea de calciu \u0219i vitamina D, p\u00e2n\u0103 la tratamente care includ \u00een prezent un bifosfonat oral de nou\u0103 genera\u021bie care are cerin\u021be de administrare flexibile pentru pacien\u021bi. Sper\u0103m ca aceste medicamente s\u0103 creeze o real\u0103 diferen\u021b\u0103 \u00een vie\u021bile femeilor din Europa\u201d, a afirmat Robert Stewart, Director executiv al Theramex.<\/p>\n\n\n\n

Livogiva este un produs biosimilar pentru medicamentul de referin\u021b\u0103 Forsteo\u00ae, teriparatid\u0103, iar echivalen\u021ba terapeutic\u0103 s-a demonstrat \u00eentr-un studiu clinic de faz\u0103 III la pacien\u021bi cu osteoporoz\u0103 sever\u0103 care au fost trata\u021bi timp de 6 luni.2<\/sup> Teriparatida este alc\u0103tuit\u0103 din secven\u021ba activ\u0103 a hormonului paratiroidian uman. Aceasta stimuleaz\u0103 formarea \u021besutului osos prin ac\u021biunea direct\u0103 asupra osteoblastelor.<\/p>\n\n\n\n

\u201eDat fiind c\u0103 osteoporoza este \u00eenc\u0103 extrem de sub-tratat\u0103, orice nou\u0103 posibilitate care va extinde op\u021biunile terapeutice disponibile pentru pacien\u021bi este binevenit\u0103. \u00centruc\u00e2t Livogiva poate fi auto-administrat de c\u0103tre pacien\u021bi prin utilizarea stiloului injector (pen-ului) preumplut, acesta are poten\u021bialul de a reduce num\u0103rul de vizite la spital \u0219i la centrele pentru osteoporoz\u0103, reduc\u00e2nd \u0219i povara asupra personalului care asigur\u0103 asisten\u021ba, economisind resurse pre\u021bioase din spital \u0219i medicale generale\u201d, a afirmat dr. Thomasius, Institutul pentru S\u0103n\u0103tate Osoas\u0103 din Frankfurt, Germania.<\/p>\n\n\n\n

Despre Livogiva<\/strong><\/p>\n\n\n\n

Livogiva este indicat pentru tratamentul osteoporozei la femei \u00een postmenopauz\u0103 cu risc crescut de fractur\u0103.2<\/sup> Studiul pivot a inclus 1.637 femei \u00een postmenopauz\u0103 (v\u00e2rsta medie 69,5 ani).2<\/sup> La momentul ini\u021bial, 90% dintre paciente au prezentat una sau mai multe fracturi vertebrale \u0219i, \u00een medie, DMO vertebral\u0103 a fost de 0,82 g\/cm2<\/sup> (echivalent unui scor T = \u2013 2,6).2<\/sup> Tuturor pacientelor li s-a administrat 1.000 mg de calciu pe zi \u0219i minimum 400 UI de vitamina D pe zi.2<\/sup> Dup\u0103 un tratament de 19 luni (\u00een medie), densitatea mineral\u0103 osoas\u0103 (DMO) a crescut la nivelul coloanei lombare \u0219i \u0219oldului cu 9% \u0219i, respectiv, 4% \u00een compara\u021bie cu placebo (p < 0,001).2<\/sup> Cele mai frecvente reac\u021bii adverse raportate la pacien\u021bii trata\u021bi cu Livogiva sunt grea\u021b\u0103, dureri ale membrelor, cefalee \u0219i ame\u021beli.2<\/sup> Livogiva poate fi prescris ca tratament de prim\u0103 linie la momentul diagnostic\u0103rii, \u00een absen\u021ba oric\u0103rei contraindica\u021bii.2<\/sup> Administrarea acestuia se face prin injectare subcutanat\u0103 zilnic\u0103.2<\/sup><\/p>\n\n\n\n

Despre Theramex<\/strong><\/p>\n\n\n\n

Theramex este una dintre principalele companii farmaceutice la nivel global dedicate femeilor \u0219i s\u0103n\u0103t\u0103\u021bii acestora. Cu un portofoliu larg de m\u0103rci inovatoare \u0219i consacrate ce acoper\u0103 domeniile contracep\u021biei, fertilit\u0103\u021bii, menopauzei \u0219i osteoporozei, sus\u021binem femeile \u00een fiecare stadiu al vie\u021bilor acestora. Suntem dedica\u021bi ascult\u0103rii \u0219i \u00een\u021belegerii pacientelor noastre, r\u0103spunderii la nevoile acestora \u0219i oferirii de solu\u021bii de s\u0103n\u0103tate care s\u0103 le ajute s\u0103 \u00ee\u0219i \u00eembun\u0103t\u0103\u021beasc\u0103 vie\u021bile. Viziunea noastr\u0103 este de a fi un partener pe via\u021b\u0103 pentru femei \u0219i profesioni\u0219tii din domeniul s\u0103n\u0103t\u0103\u021bii care le trateaz\u0103, prin furnizarea de solu\u021bii inovatoare \u0219i eficace care contribuie la \u00eengrijirea \u0219i sprijinirea femeilor pe m\u0103sur\u0103 ce acestea avanseaz\u0103 prin fiecare etap\u0103 a vie\u021bii lor.<\/p>\n\n\n\n

\n

Referin\u021be:<\/strong><\/p>\n\n\n\n

  1. IOF Compendium of Osteoporosis. 25th<\/sup> September 2019. www.osteoporosis.foundation\/sites\/iofbonehealth\/files\/2020-01\/IOF-Compendium-of-Osteoporosis-web-V02.pdf<\/a> Last accessed 6 January 2021.<\/li>
  2. Livogiva SPC https:\/\/ec.europa.eu\/health\/documents\/community-register\/2020\/20200827148839\/anx_148839_en.pdf<\/a> Last accessed 6 January 2021.<\/li><\/ol>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

    Londra, 18 ianuarie 2021: Theramex a lansat ast\u0103zi Livogiva\u00ae pentru pacien\u021bii din Europa, pentru prima dat\u0103. Tratamentul a fost lansat ini\u021bial \u00een Germania, urm\u00e2nd s\u0103 fie disponibil \u00een cur\u00e2nd \u0219i \u00een alte \u021b\u0103ri din UE, inclusiv Fran\u021ba, Italia \u0219i Spania. Livogiva este o nou\u0103 form\u0103 de prezentare a teriparatidei, singurul tratament pentru osteoporoz\u0103 cu mecanism […]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1263","post","type-post","status-publish","format-standard","hentry","category-uncategorised"],"acf":[],"yoast_head":"\nTheramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe - Theramex Romania<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe - Theramex Romania\" \/>\n<meta property=\"og:description\" content=\"Londra, 18 ianuarie 2021: Theramex a lansat ast\u0103zi Livogiva\u00ae pentru pacien\u021bii din Europa, pentru prima dat\u0103. Tratamentul a fost lansat ini\u021bial \u00een Germania, urm\u00e2nd s\u0103 fie disponibil \u00een cur\u00e2nd \u0219i \u00een alte \u021b\u0103ri din UE, inclusiv Fran\u021ba, Italia \u0219i Spania. Livogiva este o nou\u0103 form\u0103 de prezentare a teriparatidei, singurul tratament pentru osteoporoz\u0103 cu mecanism […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/\" \/>\n<meta property=\"og:site_name\" content=\"Theramex Romania\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-18T17:04:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-22T14:12:49+00:00\" \/>\n<meta name=\"author\" content=\"Mollie Neal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mollie Neal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/stiri\\\/theramex-lanseaza-livogiva\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/stiri\\\/theramex-lanseaza-livogiva\\\/\"},\"author\":{\"name\":\"Mollie Neal\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/#\\\/schema\\\/person\\\/a670d08153c0dcb98b71e52cc2b778e7\"},\"headline\":\"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe\",\"datePublished\":\"2021-01-18T17:04:00+00:00\",\"dateModified\":\"2021-06-22T14:12:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/stiri\\\/theramex-lanseaza-livogiva\\\/\"},\"wordCount\":795,\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/stiri\\\/theramex-lanseaza-livogiva\\\/\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/stiri\\\/theramex-lanseaza-livogiva\\\/\",\"name\":\"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe - Theramex Romania\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/#website\"},\"datePublished\":\"2021-01-18T17:04:00+00:00\",\"dateModified\":\"2021-06-22T14:12:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/#\\\/schema\\\/person\\\/a670d08153c0dcb98b71e52cc2b778e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/stiri\\\/theramex-lanseaza-livogiva\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.theramex.com\\\/ro\\\/stiri\\\/theramex-lanseaza-livogiva\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/stiri\\\/theramex-lanseaza-livogiva\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/#website\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/\",\"name\":\"Theramex Romania\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/#\\\/schema\\\/person\\\/a670d08153c0dcb98b71e52cc2b778e7\",\"name\":\"Mollie Neal\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/ro\\\/stiri\\\/author\\\/mollie-neal\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe - Theramex Romania","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/","og_locale":"en_GB","og_type":"article","og_title":"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe - Theramex Romania","og_description":"Londra, 18 ianuarie 2021: Theramex a lansat ast\u0103zi Livogiva\u00ae pentru pacien\u021bii din Europa, pentru prima dat\u0103. Tratamentul a fost lansat ini\u021bial \u00een Germania, urm\u00e2nd s\u0103 fie disponibil \u00een cur\u00e2nd \u0219i \u00een alte \u021b\u0103ri din UE, inclusiv Fran\u021ba, Italia \u0219i Spania. Livogiva este o nou\u0103 form\u0103 de prezentare a teriparatidei, singurul tratament pentru osteoporoz\u0103 cu mecanism […]","og_url":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/","og_site_name":"Theramex Romania","article_published_time":"2021-01-18T17:04:00+00:00","article_modified_time":"2021-06-22T14:12:49+00:00","author":"Mollie Neal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mollie Neal","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/#article","isPartOf":{"@id":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/"},"author":{"name":"Mollie Neal","@id":"https:\/\/www.theramex.com\/ro\/#\/schema\/person\/a670d08153c0dcb98b71e52cc2b778e7"},"headline":"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe","datePublished":"2021-01-18T17:04:00+00:00","dateModified":"2021-06-22T14:12:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/"},"wordCount":795,"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/","url":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/","name":"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe - Theramex Romania","isPartOf":{"@id":"https:\/\/www.theramex.com\/ro\/#website"},"datePublished":"2021-01-18T17:04:00+00:00","dateModified":"2021-06-22T14:12:49+00:00","author":{"@id":"https:\/\/www.theramex.com\/ro\/#\/schema\/person\/a670d08153c0dcb98b71e52cc2b778e7"},"breadcrumb":{"@id":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.theramex.com\/ro\/stiri\/theramex-lanseaza-livogiva\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.theramex.com\/ro\/"},{"@type":"ListItem","position":2,"name":"Theramex lanseaz\u0103 Livogiva\u00ae, un nou stilou injector (pen) preumplut cu teriparatid\u0103 pentru tratamentul osteoporozei severe"}]},{"@type":"WebSite","@id":"https:\/\/www.theramex.com\/ro\/#website","url":"https:\/\/www.theramex.com\/ro\/","name":"Theramex Romania","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.theramex.com\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.theramex.com\/ro\/#\/schema\/person\/a670d08153c0dcb98b71e52cc2b778e7","name":"Mollie Neal","url":"https:\/\/www.theramex.com\/ro\/stiri\/author\/mollie-neal\/"}]}},"_links":{"self":[{"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/posts\/1263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/comments?post=1263"}],"version-history":[{"count":8,"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/posts\/1263\/revisions"}],"predecessor-version":[{"id":1611,"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/posts\/1263\/revisions\/1611"}],"wp:attachment":[{"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/media?parent=1263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/categories?post=1263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.theramex.com\/ro\/wp-json\/wp\/v2\/tags?post=1263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}